ライフサイエンスコーパス: endoglin

1 ounding endocardium (Cx40(-), VEGFR2(-), and endoglin(+)).

2 increased motility was inhibited by soluble endoglin.

3 nase 14 (MMP-14) as the cleavage protease of endoglin.

4 is an essential receptor in angiogenesis, or endoglin.

5 signaling can compensate for the absence of endoglin.

6 tor studies showed no involvement of ALK5 or endoglin.

7 Z binding motif in the cytoplasmic domain of endoglin.

8 ith GIPC-promoting cell surface retention of endoglin.

9 evel for accessory molecules beta-glycan and endoglin.

10 l specific TGF-beta superfamily co-receptor, endoglin.

11 roduced similar effects to the inhibition of endoglin.

12 marker expression similar to that seen with endoglin.

13 erefore informed by the crystal structure of endoglin.

14 ugh the direct transcriptional regulation of Endoglin.

15 ants was clearly enhanced in the presence of endoglin.

16 interact, and that each also interacts with endoglin.

17 Interestingly, Src phosphorylation of endoglin-(612)YIY(614) was also an important process for

18 ngineering multiple tumor models deprived of endoglin, a co-receptor for TGF-beta in endothelial cell

19 factor beta (TGF-beta) type I receptor, and endoglin, a TGF-beta co-receptor, play an essential role

20 -like tyrosine kinase receptor 1 and soluble endoglin, a TGF-beta signaling inhibitor, we investigate

21 cyte migration by regulating the function of endoglin, a TGF-beta1 accessory receptor.

22 Endoglin, a transforming growth factor-beta co-receptor,

23 We previously demonstrated that endoglin, a type III transforming growth factor beta (TG

24 Here we demonstrate that endoglin abrogates TGFbeta-mediated cell motility, but d

25 TRC105, along with several other endoglin Abs tested, enhance endoglin shedding through d

26 avage substrates tissue transglutaminase and endoglin accompanied MMP-14 suppression.

27 merous vascular conditions, the mechanism of endoglin action remains poorly understood.

28 ncer progression; furthermore, they show how endoglin acts to support the viability of tumor-infiltra

29 The importance of endoglin, ALK-1, and ALK-5 in endothelial biology is und

30 ar diseases both support essential roles for endoglin, ALK-1, and ALK-5 in the vasculature.

31 Blocking of endoglin-ALK1-SMAD1/5 might be a good candidate for ther

32 n increase Smad1/5/8 signalling by promoting endoglin/ALK1 cell surface complex formation.

33 Here, we report that endoglin also plays an important role early in developme

34 Here we identified endoglin, an EC-specific TGF-beta co-receptor essential

35 Mutations in endoglin and activin-like kinase receptor 1 (ALK1) cause

36 ation via the TGF-beta superfamily receptors endoglin and activin-like kinase-1 (ALK1).

37 RNA knockdown of endoglin and ALK1 impaired SDF1/CXCR4 regulation by BMP9

38 remodeling, acting via the HHT target genes, endoglin and ALK1.

39 Although prior studies indicated that endoglin and Alk5 were not directly involved in epitheli

40 ition of pericyte migration was dependent on endoglin and alphaV integrin.

41 l therapeutics to reduce circulating soluble endoglin and ameliorate the clinical features of severe

42 oglin internalization and co-accumulation of endoglin and beta-arrestin2 in endocytic vesicles.

43 demonstrate the specific interaction between endoglin and beta-arrestin2 in endothelial cells, enhanc

44 ities of biologically active STBM associated endoglin and Flt-1/sFlt-1 could contribute to the increa

45 missing for the endothelial cell coreceptor endoglin and for the ALK1 type I receptor, which enables

46 Here we report a novel mechanism in which endoglin and Galpha-interacting protein C-terminus-inter

47 h demonstrate a specific interaction between endoglin and GIPC in endothelial cells, mediated by a cl

48 studies define a novel non-Smad function for endoglin and GIPC in regulating endothelial cell functio

49 Here we describe a novel interaction between endoglin and GIPC, a scaffolding protein known to regula

50 hing mammosphere-initiating cells, including endoglin and prion protein, will facilitate the elucidat

51 SPARC interacted directly with endoglin and reduced endoglin interaction with alphaV in

52 Placental growth factor increased, whereas endoglin and soluble vascular endothelial growth factor

53 endoglin shedding through direct coupling of endoglin and the membrane-type 1 matrix metalloproteinas

54 Here we define a novel interaction between endoglin and the scaffolding protein beta-arrestin2.

55 We established that endoglin and type II receptors bind to overlapping sites

56 In this project, the redundancy between endoglin and vascular endothelial growth factor (VEGF) s

57 Moreover, combined targeting of the endoglin and VEGF pathway, with the VEGF receptor kinase

58 These studies define a novel function for endoglin, and further expand the roles mediated by the u

59 ncluding VE-cadherin, von Willebrand factor, endoglin, and intercellular adhesion molecule-2.

60 ptor type 2, activin receptor-like kinase 1, endoglin, and mothers against decapentaplegic 9.

61 rmed expression of alpha(v)beta(3) integrin, endoglin, and VEGFR2 on tumor vascular endothelial cells

62 pression levels of alpha(v)beta(3) integrin, endoglin, and VEGFR2, which vary during tumor growth in

63 l EC-restricted genes including VE-cadherin, endoglin, and von Willebrand factor, and a negative regu

64 on either Smad 2/3 or Smad 1/5/8 activation, endoglin antagonized TGF-beta-mediated ERK signaling, al

65 detect angiogenesis using anti-VEGF and anti-endoglin (anti-CD105) and activated glial cells (anti-gl

66 of action of TRC105, an anti-angiogenic anti-Endoglin antibody currently evaluated in clinical trials

67 Our results identify endoglin as a critical component of TGFbeta1 signaling i

68 Taken together, these results establish endoglin as a critical mediator of autophagy and demonst

69 h factor, placenta growth factor, or soluble endoglin as assessed by ELISA.

70 luble fms-like tyrosine kinase-1 and soluble endoglin, as assessed by enzyme-linked immunosorbent ass

71 It does so by activating ALK2-Smad1 endoglin-associated signaling.

72 ng platform detects as few as 1000 copies of endoglin at concentrations as low as 83 fM with high det

73 e cardiac fibroblast and show that targeting endoglin attenuates cardiac fibrosis, thereby providing

74 The endoglin/beta-arrestin2 interaction results in endoglin

75 Alk5 and endoglin both mediate endothelial cell proliferation in

76 mapping analysis of the different domains of endoglin by examining their contributions to the selecti

77 have shown that the extracellular domain of endoglin can be cleaved and released into the circulatio

78 profiles demonstrated that low expression of endoglin (CD105) correlated with a subgroup of adipose-d

79 Endoglin (CD105) is an endothelial-specific transforming

80 Our array data suggested that endoglin (CD105) mRNA is significantly upregulated in HC

81 Endoglin (CD105), a receptor of the transforming growth

82 Endoglin (CD105), a transmembrane protein of the transfo

83 Cell surface endoglin (CD105), known to be expressed on proliferative

84 ing is modulated by the TGF-beta co-receptor endoglin (CD105).

85 r in wild type C57BL/6 mice (CD31(+) CD45(-) endoglin(+) cells).

86 nvolved in inflammation, strongly adhered to endoglin-coated plates and to endoglin-expressing endoth

87 was localized to the orphan domain of human endoglin composed of the amino acid sequence 26-359.

88 ese findings provide the first evidence that endoglin decreases PCa cell motility through activation

89 Moreover, the data suggest that endoglin deficiency impaired SDF1 expression in endothel

90 cient to restore a low-motility phenotype in endoglin deficient cells.

91 , genistein was shown to induce reversion of endoglin-deficient cells to a low motility, endoglin-rep

92 Tumors from endoglin-deficient mice adapted to the weakened angiogen

93 during the response to hindlimb ischemia, in endoglin-deficient mice.

94 on to a low-motility phenotype in aggressive endoglin-deficient PCa cells.

95 teins (IGFBP) in the conditioned medium from endoglin-deficient PrSCs and that endoglin-dependent reg

96 This endoglin-dependent adhesion was abolished by soluble end

97 nalling to focal adhesion kinase (FAK) in an endoglin-dependent manner.

98 d increased endothelial cell migration in an endoglin-dependent manner.

99 addressed this question by investigation of endoglin-dependent prostate cancer progression in a TRAM

100 edium from endoglin-deficient PrSCs and that endoglin-dependent regulation of IGFBP-4 secretion was c

101 Whereas endoglin did not have a direct impact on either Smad 2/3

102 ymerizing ZP proteins such as betaglycan and endoglin do not contain this cleavage site.

103 Other ZP proteins (namely, betaglycan and endoglin) do not polymerize but serve as important membr

104 Unlike endothelial cells, endoglin does not modulate Smad-mediated TGF-beta signal

105 in physiology and disease, the mechanism of endoglin down-regulation remains unknown.

106 ontrast, in the presence of activated ErbB2, endoglin downregulation in MCF10A cells leads to enhance

107 Endoglin downregulation in non-tumorigenic MCF10A breast

108 Although endoglin dysfunction contributes to numerous vascular co

109 ndings indicate an important role of soluble endoglin ECD in the regulation of angiogenesis and highl

110 Finally, murine endoglin ECD-Fc acted as an anti-angiogenic factor that

111 ane assay, the mouse and the truncated human endoglin ECD-Fc both significantly reduced VEGF-induced

112 We found that mouse and human endoglin ECD-Fc bound directly, specifically, and with h

113 A number of endoglin ectodomain-targeting antibodies (Abs) can effec

114 lts show, for the first time, that targeting endoglin, either with neutralizing antibodies or a ligan

115 determine vesicle size, purity and Flt-1 and endoglin (Eng) expression.

116 d specific promoter/enhancer combinations of Endoglin (ENG) have been shown to target blood and endot

117 Endoglin (ENG) is a coreceptor of the transforming growt

118 Endoglin (ENG), a co-receptor for several TGFbeta-family

119 Here, we show that endoglin (Eng), a receptor for the TGFbeta superfamily,

120 Endoglin (Eng), a type III receptor for the TGF-beta sup

121 Endoglin (Eng), an accessory receptor for the transformi

122 Endoglin (ENG), an ancillary receptor for several member

123 matrix metalloproteinase-2 (MMP-2), MMP-14, endoglin (ENG), and superoxide dismutase 3 in ascending

124 amily, activin-like kinase-type 1 (ALK1) and endoglin (ENG), which are associated with hereditary hem

125 Wnt signalling pathways are integrated in an endoglin (Eng)-dependent manner in cardiac and haematopo

126 strate that the TGFbeta auxiliary coreceptor endoglin (eng, CD105) is expressed in a subset of neural

127 h the RGD-containing extracellular domain of endoglin, enhanced leukocyte transmigration, and this in

128 Endoglin enhances ALK1-SMAD1/5 signaling in different ce

129 Nevertheless, tumors deprived of endoglin exhibited a delayed onset of resistance to anti

130 gly adhered to endoglin-coated plates and to endoglin-expressing endothelial cells.

131 support the notion that individuals with low endoglin-expressing PCa will benefit from genistein trea

132 We further identified that reduced endoglin expression attenuates cardiac fibrosis, preserv

133 omal cells (PrSC) confirmed that suppressing endoglin expression decreased cell proliferation, the ab

134 e cohort of invasive breast cancers, lack of endoglin expression in the tumor cell compartment correl

135 We first report that endoglin expression is increased in the left ventricle o

136 We hypothesized that reduced endoglin expression may limit cardiac fibrosis in heart

137 We here show that loss of endoglin expression mediated by either antisense DNA or

138 In this study, we have observed increased endoglin expression on the cell surface of an HCV core-e

139 We have observed endoglin expression on the HCV core-expressing cell surf

140 We identified endoglin expression on the majority of blasts from patie

141 emonstrated significantly (P </= .04) higher endoglin expression than both alpha(v)beta(3) integrin a

142 and tumor induced angiogenesis (by means of Endoglin expression).

143 nfirm these data, we assessed the effects of endoglin-Fc (an endoglin ligand trap) on metastasis form

144 on of angiogenesis and highlight efficacy of endoglin-Fc as a potential anti-angiogenesis therapeutic

145 reatment with TRC105 in the resection model, endoglin-Fc-expressing tumors showed strong inhibition o

146 ressed on endothelial cells were identified: endoglin, Fms-like tyrosine kinase-3 ligand, EGF-like re

147 alpha5beta1 integrin and endoglin form a complex on the cell surface and co-inter

148 al-specific TGF-beta superfamily coreceptor, endoglin, form a heteromeric complex and bind similar TG

149 er photobleaching (FRAP) to demonstrate that endoglin forms stable homodimers that function as a scaf

150 trasensitive detection and quantification of endoglin from unprocessed human urine samples using a gi

151 le-1 (PECAM-1), CD144/VE-cadherin, and CD106/Endoglin, from vascular endothelial cells.

152 Several agents that interfere with ALK1 and endoglin function are currently in clinical trials for a

153 nstrate that GIPC is a critical component of endoglin function during developmental angiogenesis in v

154 However the mechanism by which endoglin functions at this early developmental stage is

155 xtracellular domain (ECD) of mouse and human endoglin fused to an immunoglobulin Fc domain.

156 ereas bone morphogenetic protein-9 enhances, endoglin/GIPC-mediated membrane scaffolding of PI3K and

157 Endoglin has been identified as an important suppressor

158 This function was tested in endoglin heterozygous mice (Eng(+/-)) and their wild-typ

159 enetic protein receptor genes, ENG, encoding endoglin (HHT1), or ACVRL1 encoding ALK1 (HHT2), and con

160 aryocytic maturation, and the CD150(+)CD9(lo)endoglin(hi) fraction, which contains erythroid lineage-

161 Additionally, we observed upregulation of endoglin/ID1 mRNA expression in chronic HCV patient live

162 , an increase in alphaV integrins present in endoglin immunoprecipitates, and enhanced alphaV integri

163 s and point to a role for BMP9 signaling via endoglin in a switch from an SDF1-responsive autocrine p

164 together, these findings point to a role for endoglin in both hemangioblast specification and hematop

165 a activity and identify a novel function for endoglin in controlling pericyte behavior.

166 time points, further supports a function for endoglin in early hematopoiesis.

167 pericyte migration, aberrant association of endoglin in focal complexes, an increase in alphaV integ

168 stent with these data, ectopic expression of endoglin in MDA-MB-231 cells blocks TGF-beta-enhanced ce

169 Expression of endoglin in NCSCs declined with age, coinciding with a r

170 stablish the pathophysiologic involvement of endoglin in prostate cancer progression; furthermore, th

171 dings demonstrate a cell autonomous role for endoglin in smooth muscle cell specification contributin

172 Overexpression of endoglin in the neural crest caused pericardial hemorrha

173 at MMP-14 is the likely cleavage protease of endoglin in the setting of preeclampsia.

174 ine CXCL12, suggesting a regulatory role for endoglin in transendothelial leukocyte trafficking.

175 -like tyrosine kinase 1 (sFLT1), and soluble endoglin in trophoblasts.

176 The mechanism by which endoglin inhibits PCa cell motility is unknown.

177 transforming growth factor-beta co-receptor Endoglin inhibits the migration of prostate and breast c

178 nteracted directly with endoglin and reduced endoglin interaction with alphaV integrin.

179 onstrate for the first time that endothelial endoglin interacts with leukocyte integrin alpha5beta1 v

180 We demonstrate that endoglin interacts with the PI3K subunits p110alpha and

181 doglin/beta-arrestin2 interaction results in endoglin internalization and co-accumulation of endoglin

182 directly phosphorylates this motif to induce endoglin internalization and degradation via the lysosom

183 ed BMP9-dependent recruitment of co-receptor endoglin into this angiogenesis-mediating signaling comp

184 Endoglin is a co-receptor predominantly expressed in end

185 Membrane-associated endoglin is a coreceptor for TGFbeta1 signaling and has

186 Endoglin is a transforming growth factor beta (TGF-beta)

187 Endoglin is a transforming growth factor beta (TGF-beta)

188 Endoglin is a transforming growth factor beta (TGFbeta)

189 Endoglin is an accessory receptor for TGF-beta that has

190 Endoglin is an accessory receptor for TGFbeta and can as

191 Soluble endoglin is an anti-angiogenic protein that is released

192 Human endoglin is an RGD-containing transmembrane glycoprotein

193 Therefore, targeting endoglin is currently being explored in clinical trials

194 Although endoglin is essential for angiogenesis and its expressio

195 Here we demonstrate that endoglin is expressed in a subset of invasive breast can

196 However, the mechanism of action of endoglin is not well defined.

197 Endoglin is part of the TGF-beta receptor complex and ha

198 The mechanism through which soluble endoglin is released from the placenta is currently unkn

199 jects with heart failure and determined that endoglin is required for TGFbeta1 signaling in human car

200 ENG (endoglin) is a coreceptor for BMP (bone morphogenetic pr

201 Furthermore, the S-endoglin/L-endoglin mRNA expression ratio was significan

202 and eng(+/+) ES cells revealed that lack of endoglin leads to profound reductions in the levels of k

203 luble fms-like tyrosine kinase-1 and soluble endoglin levels and restored fetal growth in mice that w

204 ts with GM6001 decreased circulating soluble endoglin levels in mouse serum (P </= 0.05).

205 The results reveal that endoglin levels in urine have the potential to predict f

206 , we assessed the effects of endoglin-Fc (an endoglin ligand trap) on metastasis formation.

207 We now demonstrate that soluble endoglin limits TGFbeta1 signaling and type I collagen s

208 -megakaryocyte progenitor and CD150(+)CD9(hi)endoglin(lo) cells are TPO-responsive and that the latte

209 te progenitor population, the CD150(+)CD9(lo)endoglin(lo) fraction of Lin(-)cKit(+)IL7 receptor alpha

210 fraction is distinct from the CD150(+)CD9(hi)endoglin(lo) fraction, which contains bipotential precur

211 is therefore important to determine whether endoglin loss affects genistein's efficacy and, if so, b

212 luble fms-like tyrosine kinase 1 and soluble endoglin, markers thought to be related to the disease.

213 more, cell-sorting experiments revealed that endoglin marks the hemangioblast on day 3 of EB differen

214 hree types of targeted MBs (MB(Integrin), MB(Endoglin), MB(VEGFR2)) was tested in cell culture under

215 SPARC deficiency resulted in endoglin-mediated blockade of pericyte migration, aberra

216 of ALK2, but not TGFbetaRI (ALK5), abrogated endoglin-mediated decreases in cell motility and constit

217 Functionally, endoglin-mediated fibronectin/alpha5beta1 integrin and T

218 at both BMPRII and ActRIIA are necessary for endoglin-mediated suppression of human PCa cell invasion

219 Endoglin-mediated suppression of invasion was also shown

220 o type II TGFbeta receptors are required for endoglin-mediated suppression of invasion: activin A rec

221 However, the mechanism by which endoglin mediates TGF-beta signaling through ALK-1 and A

222 Endoglin modulates the crucial balance between pro- and

223 Furthermore, the S-endoglin/L-endoglin mRNA expression ratio was significantly lower i

224 ted that only NCSC expressing high levels of endoglin (NCSC(CD105+)) had myogenic differentiation pot

225 In vitro TRC105, an endoglin-neutralizing antibody, increased VEGF signaling

226 n younger explants but, by stage 16, loss of endoglin no longer alters proliferation rates.

227 tential was deficient in NCSCs obtained from endoglin null embryos.

228 ase 1 (ALK1), type II receptors, co-receptor endoglin, or to mature BMP9 domain targeting antibodies

229 Moreover, we demonstrate that Endoglin overexpression abrogates the increased migratio

230 th treatments produced a decrease in soluble endoglin (P </= 0.05).

231 d lower serum PlGF (P=0.003), higher soluble endoglin (P=0.006), and higher sFlt-1:PlGF ratio (P=0.00

232 Evaluation of the endoglin pathway suggested that enhanced osteogenesis am

233 Finally, administration of an endoglin peptide containing the consensus matrix metallo

234 ic expression of HCV core protein.IMPORTANCE Endoglin plays a crucial role in fibrogenesis and angiog

235 Here we show that PRH can bind to the Endoglin promoter in immortalised prostate and breast ce

236 Overall, endoglin promotes autophagy by impeding Smad2 transcript

237 EMT) in the heart, the expression pattern of endoglin prompted a re-examination.

238 pression in these cells results in increased Endoglin protein expression, whereas PRH knockdown resul

239 , whereas PRH knockdown results in decreased Endoglin protein expression.

240 19, P=0.02); at 18 to 25 weeks, with soluble endoglin (r=0.18, P=0.02); and at 26 to 33 weeks, with s

241 satility index correlated with serum soluble endoglin (r=0.19, P=0.02) and sFlt-1 levels (r=0.17, P=0

242 llular distribution studies demonstrate that endoglin recruits GIPC to the plasma membrane and co-loc

243 We propose that endoglin regulates primitive hematopoiesis by modulating

244 s also the mechanism responsible for soluble endoglin release in preeclampsia, we investigated the ex

245 and the effects of its inhibition on soluble endoglin release.

246 endoglin-deficient cells to a low motility, endoglin-replete phenotype.

247 Mutations in endoglin result in the vascular defect known as heredita

248 odels of cancer revealed that deficiency for endoglin resulted in a tumor vasculature that displayed

249 -dependent adhesion was abolished by soluble endoglin, RGD peptides, the anti-integrin alpha5beta1 in

250 wn of Smad1 increased motility and abrogated endoglin's effects.

251 Soluble Flt1 and soluble endoglin, secreted by the placenta, are increased in the

252 wth factor receptor-1 [VEGFR-1]) and soluble endoglin (sEng) are elevated in preeclampsia, and their

253 A soluble form of endoglin (sEng) has been shown to cause endothelial dysf

254 pregnancy-specific syndrome in which soluble endoglin (sEng) is a prognostic marker and plays a patho

255 of this study was to compare plasma soluble endoglin (sEng) levels with standard clinical evaluation

256 mma-lyase (CSE) increases sFlt-1 and soluble endoglin (sEng) release.

257 e circulating antiangiogenic factor, soluble endoglin (sEng), is elevated in the blood circulation of

258 P), alpha-1-acid glycoprotein (AGP), soluble endoglin (sEng), soluble fms-like tyrosine kinase-1 (sFl

259 -like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng).

260 o release the antiangiogenic factor, soluble endoglin (sEng).

261 n Molecule-1 [sICAM-1]), angiogenic (soluble Endoglin [sEng]), and metabolic mediators (Leptin, Angio

262 Collectively, our study defines endoglin shedding and deregulated TGF-beta signaling dur

263 In addition to this coupling process, endoglin shedding is further amplified by increased MMP-

264 h several other endoglin Abs tested, enhance endoglin shedding through direct coupling of endoglin an

265 In patient samples, increased endoglin signaling after VEGF inhibition was observed.

266 fine a novel mechanism for the regulation of endoglin signaling and function in endothelial cells and

267 ion by HCV core protein was dependent on the endoglin signaling pathway using activin receptor-like k

268 c response, and refractoriness to diminished endoglin signaling was accompanied by increased metastat

269 oding activin receptor-like kinase 1 (ALK1), endoglin, Smad4, and bone morphogenetic protein 9 (BMP9)

270 like kinase 1 (ALK1) Fc blocking peptide and endoglin small interfering RNA (siRNA).

271 Endoglin specifically enhanced TGF-beta1-induced phospho

272 angiogenic mitogens as critical mediators of endoglin stability and function.

273 Because endoglin suppresses PCa cell motility in an activin-like

274 on Smad activation, but were associated with endoglin suppression and accentuated expression of bone

275 or down-regulation by TRACON105 (TRC105), an endoglin-targeting antibody currently in clinical trials

276 of cell surface markers, including CD105 (or endoglin), Thy1 [or CD90 (cluster of differentiation 90)

277 loy the first transgenic zebrafish model for endoglin to demonstrate that GIPC is a critical componen

278 tion in a manner dependent on the ability of endoglin to interact with beta-arrestin2.

279 tion in a manner dependent on the ability of endoglin to interact with GIPC.

280 dothelial phenotype (Cx40(+), VEGFR2(+), and endoglin(-)) to the surrounding endocardium (Cx40(-), VE

281 te transmigration through cell monolayers of endoglin transfectants was clearly enhanced in the prese

282 ac fibroblasts and further show that soluble endoglin treatment attenuates cardiac fibrosis in an in

283 factor (VEGF) as Src-activators that induce endoglin turnover following (612)YIY(614) phosphorylatio

284 complexes, levels of neoangiogenesis marker Endoglin, vascular density, and cerebral blood flow reco

285 ogical activity of STBM associated Flt-1 and endoglin was assessed by the ability of VEGF, PlGF and T

286 ocarcinoma mouse prostate) mouse model where endoglin was genetically deleted.

287 In this model, endoglin was haploinsufficient such that its allelic del

288 ation and Smad-responsive promoter activity, endoglin was shown to constitutively activate Smad1, wit

289 Soluble endoglin was strongly correlated with sFlt1 and PlGF lev

290 The soluble form of endoglin was suggested to contribute to the pathogenesis

291 trate that this interaction produces soluble endoglin, we treated trophoblastic BeWo cells with eithe

292 As Alk5 interacts with endoglin, we utilized siRNA and a specific inhibitor, HT

293 Plasma levels of BMP9 and antagonist soluble endoglin were measured in group 1 PAH, group 2 and 3 pul

294 like tyrosine kinase 1 (sFlt-1), and soluble endoglin were prospectively measured in 159 women from 1

295 NFalpha) and myeloid differentiation factor (Endoglin) were increased in myeloid cells from p65 KO tu

296 and released into the circulation as soluble endoglin, which disrupts TGFbeta1 signaling in endotheli

297 directly to the TGF-beta accessory receptor endoglin, which, in the presence of TGF-beta1, results i

298 ALK1 and ALK5 bind to endoglin with differential dependence on TbetaRII, which

299 owever, the pathophysiologic significance of endoglin with respect to prostate tumorigenesis has yet

300 n interactions between endogenous MMP-14 and endoglin within the preeclamptic placenta.